Generative AI In Pharma Market Will Grow Nearly USD 2258.1 Mn At A Rate Of 31.2% By 2032
Generative AI in the pharmaceutical industry has emerged as a powerful tool for drug discovery and design. Its ability to create novel molecular structures and optimize drug candidates accelerates the development process. The demand for such AI solutions is on the rise, promising increased efficiency, personalized medicine, and potential collaborations between pharma companies and technology firms. However, regulatory challenges may arise as the industry integrates generative AI into drug development pipelines, necessitating the establishment of guidelines to ensure safety and efficacy. The segmentation of the Generative AI in Pharma market can be based on applications such as drug discovery, target…
- Date: July 31, 2023
- Author: Robert Shaw
- Category: Taiwan News